Associated Papers
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.
Ng J et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
38180245 (PubMed )
Supplement: ccr-23-2360_supplementary_table_s4_suppst4.xlsx › S.Table_4
Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients.
Fernando TM et al.
Nature Communications, 2020
33144586 (PubMed )
Supplement: 41467_2020_19402_MOESM4_ESM.xlsx › Sheet1
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers.
Hodges HC et al.
Nature Structural & Molecular Biology, 2018
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
Stanton BZ et al.
Nature Genetics, 2017
Select a paper to view details